48 results on '"Poklis, Justin L"'
Search Results
2. Correction to: Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release
3. N-oleoyl alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice
4. Effects of acute Δ9-tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
5. Ethyl Acetate in E-liquids: Implications for Breath Testing
6. Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
7. Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
8. Ivabradine toxicity: a case report
9. Inactivation of fatty acid amide hydrolase protects against ischemic reperfusion injury-induced renal fibrogenesis
10. Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice
11. Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.
12. Systematic Structure–Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments.
13. Correction to: Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release
14. The role of morphine-and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axis.
15. Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm.
16. Effects of Acute Cannabidiol on Behavior and the Endocannabinoid System in HIV-1 Tat Transgenic Female and Male Mice
17. Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release
18. Effects of acute Δ9-tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
19. The preanalytical stability of emerging cannabinoid analogs (delta-8 THC and its metabolites, delta-10 THC and carboxy-HHC) in urine
20. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays
21. The impact of vaping ethanol-containing electronic cigarette liquids on roadside impairment investigations
22. High‐performance liquid chromatography‐tandem mass spectrometry method for the analysis of N‐oleoyl glycine and N‐oleoyl alanine in brain and plasma.
23. A determination of the aerosolization efficiency of drugs of abuse in a eutectic mixture with nicotine in electronic cigarettes.
24. Cannabinoid‐based vaping products and supplement formulations reported by consumers to precipitate adverse effects.
25. The history, evolution, and practice of cannabis and E-cigarette industries highlight necessary public health and public safety considerations
26. Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm
27. Direct analysis of tobacco specific nitrosamines in tobacco products using a molecularly imprinted polymer-packed column
28. Effects of acute Δ9 -tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
29. Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
30. A determination of the aerosolization efficiency of drugs of abuse in a eutectic mixture with nicotine in electronic cigarettes
31. Determination of Patient Adherence for Duloxetine in Urine
32. ∆8-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles
33. Cannabinoid‐based vaping products and supplement formulations reported by consumers to precipitate adverse effects
34. Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists
35. Additional file 1 of Ivabradine toxicity: a case report
36. A Retrospective Analysis of Chemical Constituents in Regulated and Unregulated E-Cigarette Liquids
37. Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat
38. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
39. Identification of Gamma-Butyrolactone in JUUL Liquids.
40. Neonatal Exposure to Tramadol through Mother's Breast Milk.
41. High performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method for detection and quantification of select NLRP3 inhibitors from brain tissue
42. Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine.
43. Mitigation of cisplatin-induced acute kidney injury through oral administration of FAAH Inhibitor PF-04457845 .
44. A Multi-Year Characterization of Confiscated Vaping Products from Virginia School Youth.
45. NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties .
46. Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice.
47. Differences across sexes on head-twitch behavior and 5-HT 2A receptor signaling in C57BL/6J mice.
48. Direct analysis of tobacco specific nitrosamines in tobacco products using a molecularly imprinted polymer-packed column.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.